NVDA+0.84%AAPL−2.51%GOOGL−1.17%MSFT−2.04%AMZN−0.15%TSM+2.85%SPCX−1.20%AVGO+0.21%
StockVS

NASDAQ · Health Information Services · USD

DarioHealth Corp. (DRIO) Stock Analysis

DarioHealth Corp. (DRIO) is a Health Information Services stock listed on NASDAQ and quoted in US Dollar.

DRIO

$7.24

+$0.26 (+3.72%)

Sep 4, 2026 · Market close

Compare

Price History

Hover for the daily close. The dotted line marks the period open.

Compare DRIO with… →

DRIO Key Statistics

As of Sep 4, 2026
Trading
Open
$6.94
Previous Close
$6.98
Day's Range
6.79–7.30
52-Week Range
5.85–17.74
Volume
20.60K
BetaHow much the share price moves relative to the wider market. 1.0 moves in line with it; above 1.0 swings more, below 1.0 less.
1.12
Valuation
Market Cap
$70.95M
P/E Ratio
unprofitable
P/S ratioMarket value divided by annual revenue. Useful for companies that are not yet profitable, where a P/E cannot be calculated.
3.38
EPS (ttm)Profit attributable to each share over the last twelve months.
−14.87
Financials (FY)
Revenue (FY)
$22.36M−17.31%
Net Income (FY)
−$41.71M
Profit marginThe share of revenue left as profit after all costs and taxes.
−169.87%
Shares OutstandingThe total number of shares held by all investors. Market value is this figure multiplied by the share price.
9.80M
1-Year Return
−29.16%
Dividend and dates
Earnings Date
November 12, 2026estimated
Avg Volume
22.30K

Only metrics the company reports are shown. Data provided by Yahoo Finance via yfinance. Updated daily.

DRIO Stock Return by Calendar Year

Calendar-year returns computed from daily closing prices. Partial years are shown muted and marked with an asterisk.

YearReturn
2026 (partial year)−36.38%
2025−27.61%
2024−54.30%
2023−59.81%
2022−67.00%
2021−9.24%
2020+117.84%
2019+745.36%
2018−51.56%
2017−50.71%
2016 (partial year)−18.95%

As of September 4, 2026.

DRIO Revenue and Earnings by Fiscal Year

FY ends December
Fiscal yearRevenueNet incomeNet margin
2025$22.36M−$41.71M−186.6%
2024$27.04M−$42.75M−158.1%
2023$20.35M−$59.43M−292.0%
2022$27.66M−$62.19M−224.9%
Fiscal yearRevenueGross profitOperating incomeNet incomeNet margin
2025$22.36M$12.67M−$36.66M−$41.71M−186.6%
2024$27.04M$13.27M−$57.74M−$42.75M−158.1%
2023$20.35M$5.98M−$56.19M−$59.43M−292.0%
2022$27.66M$9.66M−$56.81M−$62.19M−224.9%

Annual figures as reported, in the company's reporting currency. As of December 31, 2025.

DRIO Valuation vs Health Information Services Median

Median of 53 stocks
MetricDRIOHealth Information Services medianvs median
P/S ratio3.382.6627% above
Profit margin−169.87%0.00%169.9 pts below

Medians across 53 Health Information Services stocks that report the metric. Medians, not averages, so one outlier cannot move them. As of September 4, 2026.

Recent News

All 11 articles ↓

News provided by third-party sources. Not financial advice.

Analysis

Data-derived

Company Overview

The market values DarioHealth Corp. (DRIO) at $70.95M. It is classified in the Health Information Services industry, within the Healthcare sector. The company reports 160 employees.

The most recent close on file for DRIO is $7.24, dated September 4, 2026. That is +$0.26 (+3.72%) against the previous close. Over the past 52 weeks the price has ranged from $5.85 to $17.74. The latest close sits 23.87% above that 52-week low.

Financial Health

Fiscal 2025 revenue came to $22.36M. Against the prior fiscal year total of $27.04M, that is a change of −17.31%. The same year closed with a net loss of $41.71M. Profit margin runs at −169.87%. That is 169.9 percentage points below the Health Information Services median of 0%. Earnings per share on a trailing basis come to −14.87.

Across the 4 fiscal years on file, revenue moves from $27.66M in 2022 to $22.36M in 2025. Of those 4 years, 0 report positive net income.

Valuation Assessment

The record shows negative trailing earnings, so no price-to-earnings ratio is published. Measured against sales, the shares trade at 3.38 times revenue. On price-to-sales that is 27.08% above the Health Information Services median of 2.66. The medians here are taken across 53 Health Information Services companies that report the metric.

The trailing one-year price return is −29.16%. Across 10 years the annualized return works out at −21.39%. Beta against the wider market is reported at 1.12. Daily returns over the trailing 10 years annualize to a volatility of 633.97%.

Growth & Income

The record shows no dividend for DRIO.

The strongest complete calendar year on file is 2019 at +745.36%; the weakest is 2022 at −67.00%. Of the 9 complete calendar years on file, 2 finished higher. So far in 2026 the price is −36.38%.

Peer Comparison

DarioHealth Corp. (DRIO) operates in the Health Information Services industry. Here is how it compares to its closest peers by market capitalization:

Company Ticker Market Cap P/E Ratio
DarioHealth Corp. DRIO $70.95M —
Veeva Systems Inc. VEEV $44.54B 45.0
BrightSpring Health Services, Inc. BTSG $12.02B 54.7
Tempus AI, Inc. TEM $11.66B —

The Health Information Services industry average P/E ratio is 41.1x. DarioHealth Corp. has no P/E ratio because it is not currently profitable.

Every figure above is read from this page's own data on each nightly rebuild. Informational only, not financial advice. As of September 4, 2026.

Related Health Information Services Stocks

VEEV

Veeva Systems Inc.

$44.54B

 BTSG

BrightSpring Health Services, Inc.

$12.02B

 TEM

Tempus AI, Inc.

$11.66B

 HQY

HealthEquity, Inc.

$7.95B

 HNGE

Hinge Health, Inc.

$7.45B

 WAY

Waystar Holding Corp.

$4.81B
View all Health Information Services stocks →

Popular Healthcare Stocks

LLY

Eli Lilly and Company

$1.02T

 JNJ

Johnson & Johnson

$663.28B

 ABBV

AbbVie Inc.

$453.19B

 MRK

Merck & Co., Inc.

$370.89B

 UNH

UnitedHealth Group Incorporated

$356.47B
View all Healthcare stocks →

About DarioHealth Corp.

DarioHealth Corp. operates as a digital health company in the United States and internationally. Its digital therapeutics platform and suite of solutions deliver personalized and dynamic interventions driven by data analytics and one-on-one coaching for diabetes, hypertension, weight management, musculoskeletal pain, and behavioral health. The company offers Dario Connect, a solution used to create communities around specific health conditions to increase awareness and education; Dario Mind, a behavioral health offering that decreases the symptoms of stress, anxiety, and depression; Dario Move, focuses on improving posture to alleviate pain with medical device; and Dario Health, a self-care application and virtual coaching platform for diabetes, hypertension, and weight management and GLP-1. It also provides bundled full-suite or partial-suite subscriptions. The company was formerly known as LabStyle Innovations Corp. and changed its name to DarioHealth Corp. in July 2016. DarioHealth Corp. was incorporated in 2011 and is based in New York, New York.

Visit website →